Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2025 年第 2 季持倉
持倉截至 2025/6/30，2025/8/14 申報。只含多頭部位，變化是跟 2025 年第 1 季比股數。
- 持股檔數
- 55
- 較 2025 年第 1 季 −8
- 總值
- $4.99 億
- 較 2025 年第 1 季 +$1,394 萬 (+2.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| CGONCG Oncology, Inc. | COM | 1,499,942 | $3,900 萬 | 7.8% | +519,000+52.9% | 加碼 | 歷史 |
| BSXBoston Scientific Corp | Stock | 321,800 | $3,456 萬 | 6.9% | −14,200−4.2% | 減碼 | 歷史 |
| NTRANatera, Inc. | COM | 199,300 | $3,367 萬 | 6.8% | +80,100+67.2% | 加碼 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 1,742,902 | $3,247 萬 | 6.5% | +22,000+1.3% | 加碼 | 歷史 |
| EXASExact Sciences Corp | COM | 355,000 | $1,886 萬 | 3.8% | +2,000+0.6% | 加碼 | 歷史 |
| THCTenet Healthcare Corp | COM NEW | 106,000 | $1,866 萬 | 3.7% | +34,000+47.2% | 加碼 | 歷史 |
| DXCMDexcom Inc | COM | 210,500 | $1,837 萬 | 3.7% | +30,500+16.9% | 加碼 | 歷史 |
| DHRDanaher Corp | Stock | 89,700 | $1,772 萬 | 3.6% | +45,200+101.6% | 加碼 | 歷史 |
| HNGEHinge Health, Inc. | CL A | 322,344 | $1,668 萬 | 3.3% | +322,344 | 新進 | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 27,100 | $1,473 萬 | 3.0% | +27,100 | 新進 | 歷史 |
| GMABGenmab A/S | SPONSORED ADS | 650,000 | $1,343 萬 | 2.7% | +650,000 | 新進 | 歷史 |
| RGENRepligen Corp | COM | 106,500 | $1,325 萬 | 2.7% | +106,500 | 新進 | 歷史 |
| TMOThermo Fisher Scientific Inc. | Stock | 29,600 | $1,200 萬 | 2.4% | +14,100+91.0% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 689,500 | $1,156 萬 | 2.3% | +208,500+43.3% | 加碼 | 歷史 |
| JBIOJade Biosciences, Inc. | COM NEW | 1,127,186 | $1,126 萬 | 2.3% | +1,127,186 | 新進 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,064,500 | $1,021 萬 | 2.0% | +264,500+33.1% | 加碼 | 歷史 |
| UNHUnitedHealth Group Inc | Stock | 32,000 | $998.3 萬 | 2.0% | −18,500−36.6% | 減碼 | 歷史 |
| MCKMcKesson Corp | Stock | 13,500 | $989.3 萬 | 2.0% | +13,500 | 新進 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 94,500 | $986.5 萬 | 2.0% | +17,500+22.7% | 加碼 | 歷史 |
| CORCencora, Inc. | Stock | 32,800 | $983.5 萬 | 2.0% | −6,500−16.5% | 減碼 | 歷史 |
| HQYHealthequity, Inc. | COM | 92,000 | $963.8 萬 | 1.9% | +14,000+17.9% | 加碼 | 歷史 |
| EHCEncompass Health Corp | COM | 74,000 | $907.5 萬 | 1.8% | +74,000 | 新進 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 228,600 | $841.0 萬 | 1.7% | +15,600+7.3% | 加碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 134,000 | $715.0 萬 | 1.4% | +77,000+135.1% | 加碼 | 歷史 |
| OMDAOmada Health, Inc. | COM | 390,600 | $714.8 萬 | 1.4% | +390,600 | 新進 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 409,400 | $696.4 萬 | 1.4% | −300,117−42.3% | 減碼 | 歷史 |
| HUMHumana Inc | Stock | 27,600 | $674.8 萬 | 1.4% | −53,400−65.9% | 減碼 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 1,858,596 | $639.4 萬 | 1.3% | −338,674−15.4% | 減碼 | 歷史 |
| OGNOrganon & Co. | Stock | 640,000 | $619.5 萬 | 1.2% | +105,000+19.6% | 加碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 140,000 | $604.5 萬 | 1.2% | +65,000+86.7% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 59,000 | $593.8 萬 | 1.2% | −48,000−44.9% | 減碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 19,000 | $575.0 萬 | 1.2% | +19,000 | 新進 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 154,000 | $559.9 萬 | 1.1% | −168,100−52.2% | 減碼 | 歷史 |
| CNTXContext Therapeutics Inc. | COM | 7,477,255 | $489.9 萬 | 1.0% | +550.0% | 加碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 352,124 | $394.7 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| IMUXImmunic, Inc. | COM | 5,615,811 | $391.7 萬 | 0.8% | +1,161,403+26.1% | 加碼 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 268,000 | $375.7 萬 | 0.8% | +268,000 | 新進 | 歷史 |
| DOCSDoximity, Inc. | CL A | 60,000 | $368.0 萬 | 0.7% | −62,500−51.0% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 107,891 | $337.7 萬 | 0.7% | −121,109−52.9% | 減碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 33,800 | $319.7 萬 | 0.6% | +33,800 | 新進 | 歷史 |
| QUREuniQure N.V. | SHS | 207,000 | $288.6 萬 | 0.6% | −129,200−38.4% | 減碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 65,000 | $282.3 萬 | 0.6% | +65,000 | 新進 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 32,000 | $268.1 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| CAHCardinal Health Inc | Stock | 15,000 | $252.0 萬 | 0.5% | +15,000 | 新進 | 歷史 |
| SPRYARS Pharmaceuticals, Inc. | COM | 140,000 | $244.3 萬 | 0.5% | +140,000 | 新進 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 502,600 | $230.2 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 232,000 | $217.6 萬 | 0.4% | +232,000 | 新進 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 39,000 | $184.1 萬 | 0.4% | +39,000 | 新進 | 歷史 |
| ARVNArvinas, Inc. | COM | 243,162 | $179.0 萬 | 0.4% | −170,000−41.1% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 150,000 | $140.5 萬 | 0.3% | −775,000−83.8% | 減碼 | 歷史 |
| SCYXScynexis Inc | COM NEW | 1,228,910 | $82.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 134,566 | $58.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 105,000 | $40.6 萬 | 0.1% | +105,000 | 新進 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 11,300 | $22.7 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RVPHReviva Pharmaceuticals Holdings, Inc. | COM | 138,000 | $5.26 萬 | <0.1% | 00.0% | 不變 | 歷史 |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SNDXSyndax Pharmaceuticals Inc | COM | – | $318.4 萬 |
2025 年第 1 季之後清倉（25 檔）
2025 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 1 季股數 | 2025 年第 1 季市值 | 2025 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| REGNRegeneron Pharmaceuticals, Inc. | COM | 25,400 | $1,611 萬 | 3.3% | 歷史 |
| GKOSGLAUKOS Corp | COM | 134,000 | $1,319 萬 | 2.7% | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 80,000 | $993.2 萬 | 2.0% | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 85,700 | $947.8 萬 | 2.0% | 歷史 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 94,000 | $762.3 萬 | 1.6% | – |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 529,000 | $760.7 萬 | 1.6% | 歷史 |
| AVTRAvantor, Inc. | COM | 453,000 | $734.3 萬 | 1.5% | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 445,000 | $728.9 萬 | 1.5% | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 258,000 | $696.6 萬 | 1.4% | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 68,500 | $606.3 萬 | 1.3% | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 16,800 | $517.9 萬 | 1.1% | 歷史 |
| BRKRBruker Corp | COM | 115,000 | $480.0 萬 | 1.0% | 歷史 |
| BHVNBiohaven Ltd. | COM | 145,000 | $348.6 萬 | 0.7% | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 169,000 | $280.7 萬 | 0.6% | 歷史 |
| RPRXRoyalty Pharma plc | SHS CLASS A | 87,000 | $270.8 萬 | 0.6% | 歷史 |
| CAPRCapricor Therapeutics, Inc. | COM NEW | 239,000 | $226.8 萬 | 0.5% | 歷史 |
| LXEOLexeo Therapeutics, Inc. | COM | 645,000 | $223.8 萬 | 0.5% | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 91,000 | $218.6 萬 | 0.5% | 歷史 |
| RGNXREGENXBIO Inc. | COM | 260,000 | $185.9 萬 | 0.4% | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 60,000 | $181.0 萬 | 0.4% | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 40,000 | $180.2 萬 | 0.4% | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 68,000 | $139.2 萬 | 0.3% | 歷史 |
| AGLagilon health, inc. | COM | 305,100 | $132.1 萬 | 0.3% | 歷史 |
| PCVXVaxcyte, Inc. | COM | 23,000 | $86.8 萬 | 0.2% | 歷史 |
| HYPRHyperfine, Inc. | COM CL A | 222,174 | $15.9 萬 | <0.1% | 歷史 |